COM:MERSANA
Mersana Therapeutics
- Stock
Last Close
2.22
21/11 21:00
Market Cap
239.83M
Beta: -
Volume Today
1.01M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 10.36M - | 25.17M 142.99% | 17.55M 30.30% | 10.59M 39.62% | 42.12M 297.61% | 828K 98.03% | 43K 94.81% | 26.58M 61,716.28% | 36.85M 38.65% | |
cost of revenue | 1.52M - | |||||||||
gross profit | 10.36M - | 25.17M 142.99% | 17.55M 30.30% | 10.59M 39.62% | 42.12M 297.61% | 828K 98.03% | 43K 94.81% | 26.58M 61,716.28% | 35.34M 32.94% | |
selling and marketing expenses | -1.52M - | |||||||||
general and administrative expenses | 5.35M - | 6.98M 30.62% | 10.46M 49.80% | 16.33M 56.13% | 17.28M 5.81% | 21.90M 26.73% | 36.89M 68.42% | 56.96M 54.42% | 59.54M 4.53% | |
selling general and administrative expenses | 5.35M - | 6.98M 30.62% | 10.46M 49.80% | 16.33M 56.13% | 17.28M 5.81% | 21.90M 26.73% | 36.89M 68.42% | 56.96M 54.42% | 58.03M 1.87% | |
research and development expenses | 21.35M - | 32.01M 49.90% | 46.70M 45.90% | 59.91M 28.30% | 55.04M 8.14% | 67.04M 21.80% | 132.01M 96.93% | 173.38M 31.34% | 148.27M 14.49% | |
other expenses | -89K - | 1.40M - | -1.20M - | -445K 62.98% | 8.71M 2,057.98% | |||||
cost and expenses | 26.70M - | 38.99M 46.04% | 57.16M 46.60% | 76.25M 33.39% | 72.32M 5.15% | 88.94M 22.97% | 168.90M 89.91% | 230.35M 36.38% | 207.81M 9.78% | |
operating expenses | 26.70M - | 38.99M 46.04% | 57.16M 46.60% | 76.25M 33.39% | 72.32M 5.15% | 88.94M 22.97% | 168.90M 89.91% | 230.35M 36.38% | 206.29M 10.44% | |
interest expense | 234K - | 359K 53.42% | 1.27M 252.92% | 3.33M 162.67% | 4.07M 22.39% | |||||
ebitda | -16.04M - | -13.17M 17.94% | -38.69M 193.86% | -65.66M 69.70% | -27.97M 57.39% | -86.68M 209.84% | -168.86M 94.82% | -203.77M 20.67% | -169.44M 16.85% | |
operating income | -16.34M - | -13.82M 15.42% | -39.62M 186.64% | -65.66M 65.72% | -29.22M 55.50% | -87.69M 200.10% | -169.71M 93.55% | -204.69M 20.61% | -170.96M 16.48% | |
depreciation and amortization | 297K - | 655K 120.54% | 928K 41.68% | 1.26M 35.45% | 1.25M 0.95% | 1.01M 18.88% | 855K 15.35% | 927K 8.42% | 1.52M 63.65% | |
total other income expenses net | -89K - | 121K 235.96% | 910K 652.07% | 1.40M 53.63% | 1.01M 27.68% | -359K 135.51% | -347K 3.34% | 482K 238.90% | -713K 247.93% | |
income before tax | -16.43M - | -13.70M 16.61% | -38.71M 182.53% | -64.26M 66.01% | -28.21M 56.10% | -88.05M 212.13% | -170.06M 93.15% | -204.21M 20.08% | -171.67M 15.94% | |
income tax expense | -2K - | 1.40M - | -1.01M 172.32% | 359K 135.51% | -855K 338.16% | 3.33M 489.24% | ||||
net income | -16.43M - | -13.70M 16.61% | -38.71M 182.53% | -64.26M 66.01% | -27.20M 57.67% | -88.40M 225.05% | -169.21M 91.40% | -207.54M 22.66% | -171.67M 17.28% | |
weighted average shs out | 17.49M - | 17.49M 0% | 12.02M 31.27% | 23.03M 91.57% | 43.49M 88.83% | 61.49M 41.37% | 70.58M 14.79% | 93.65M 32.69% | 116.11M 23.98% | |
weighted average shs out dil | 17.49M - | 17.49M 0% | 12.02M 31.27% | 23.03M 91.57% | 43.49M 88.83% | 61.49M 41.37% | 70.58M 14.79% | 93.65M 32.69% | 116.11M 23.98% | |
eps | -0.94 - | -0.78 17.02% | -3.22 312.82% | -2.79 13.35% | -0.63 77.42% | -1.44 128.57% | -2.40 66.67% | -2.22 7.50% | -1.48 33.33% | |
epsdiluted | -0.94 - | -0.78 17.02% | -3.22 312.82% | -2.79 13.35% | -0.63 77.42% | -1.44 128.57% | -2.40 66.67% | -2.22 7.50% | -1.48 33.33% |
All numbers in (except ratios and percentages)